INTERCURE, which calls itself the ‘most profitable and fastest growing’ cannabis company outside of North America, is poised to open a number of cannabis...
CONSERVATIVE MPs have blocked efforts to boost UK medical cannabis access with the Government saying the existing legislation is sufficient.
With just three prescriptions written...
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.
The deal will...
Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis Industry Council’s (CIC) Research group.
With...
CLAIMS a Canadian cannabis producer misled investors over its purchase of a UK horticultural farm have been dismissed by a New York court.
While raising...
Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”) (together, the “Group”), a company developing licensed prescription cannabinoid...